How to read and understand Registries for Evaluating Patient Outcomes: A User's Guide (2nd Edition).
- Author:
Wei YANG
1
;
Yan-Ming XIE
2
;
null
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. ywonline@163.com
2. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Publication Type:Guideline
- MeSH:
Books;
Drug Therapy;
Drugs, Chinese Herbal;
standards;
therapeutic use;
Humans;
Observational Studies as Topic;
Outcome Assessment (Health Care);
organization & administration;
standards;
Patient Selection;
Pragmatic Clinical Trials as Topic;
Registries;
standards;
United States;
United States Agency for Healthcare Research and Quality
- From:
China Journal of Chinese Materia Medica
2013;38(18):2958-2962
- CountryChina
- Language:Chinese
-
Abstract:
Registry studies (RS) get more and more attention in recent years because it can reflect the health care situations of the real world. There are a number of large scale RS for traditional Chinese medicine (TCM). RS are observational studies that can complement randomized controlled trials (RCT). RS have an irreplaceable position in real word study (RWS), especially for small probability events. There are some different characters and qualities in RS. Registries for Evaluating Patient Outcomes: A User's Guide (2nd Edition) was published by the agency for healthcare research and quality (AHRQ) in 2010. It described the details of how to establish, maintain, and evaluate RS, and using 38 RS samples to illustrate the possible problems in undertaking such research. The User's Guide (2nd Edition) provides a reliable reference document for RS. TCM injections post-marketing safety surveillance RS is a national program involving multiple centers in China. This program can further improve RS quality their application in China and is a good illustration of how to follow this guide accurately.
